Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-002406
Filing Date
2024-03-05
Accepted
2024-03-05 06:15:46
Documents
128
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apge-20231231x10k.htm   iXBRL 10-K 2953092
2 EX-4.3 apge-20231231xex4d3.htm EX-4.3 36428
3 EX-10.6 apge-20231231xex10d6.htm EX-10.6 58406
4 EX-23.1 apge-20231231xex23d1.htm EX-23.1 2932
5 EX-31.1 apge-20231231xex31d1.htm EX-31.1 11484
6 EX-31.2 apge-20231231xex31d2.htm EX-31.2 11591
7 EX-32.1 apge-20231231xex32d1.htm EX-32.1 8536
8 EX-97.1 apge-20231231xex97d1.htm EX-97.1 29321
9 GRAPHIC apge-20231231x10k006.jpg GRAPHIC 36791
10 GRAPHIC apge-20231231x10k007.jpg GRAPHIC 25513
11 GRAPHIC apge-20231231x10k008.jpg GRAPHIC 69792
12 GRAPHIC apge-20231231x10k009.jpg GRAPHIC 25347
13 GRAPHIC apge-20231231x10k010.jpg GRAPHIC 20979
14 GRAPHIC apge-20231231x10k011.jpg GRAPHIC 19949
15 GRAPHIC apge-20231231x10k012.jpg GRAPHIC 70653
16 GRAPHIC apge-20231231x10k014.jpg GRAPHIC 24552
17 GRAPHIC apge-20231231x10k016.jpg GRAPHIC 15632
18 GRAPHIC apge-20231231x10k018.jpg GRAPHIC 51494
19 GRAPHIC apge-20231231x10k020.jpg GRAPHIC 47149
20 GRAPHIC apge-20231231x10k021.jpg GRAPHIC 40216
21 GRAPHIC apge-20231231x10k022.jpg GRAPHIC 29320
22 GRAPHIC apge-20231231x10k023.jpg GRAPHIC 22905
23 GRAPHIC apge-20231231x10k025.jpg GRAPHIC 19048
24 GRAPHIC apge-20231231x10k026.jpg GRAPHIC 26471
25 GRAPHIC apge-20231231x10k028.jpg GRAPHIC 38100
26 GRAPHIC apge-20231231x10k029.jpg GRAPHIC 40769
27 GRAPHIC apge-20231231x10k030.jpg GRAPHIC 101998
28 GRAPHIC apge-20231231x10k031.jpg GRAPHIC 21242
29 GRAPHIC apge-20231231x10k033.jpg GRAPHIC 42262
30 GRAPHIC apge-20231231x10k034.jpg GRAPHIC 24030
31 GRAPHIC apge-20231231x10k037.jpg GRAPHIC 15163
32 GRAPHIC apge-20231231x10k039.jpg GRAPHIC 52525
33 GRAPHIC apge-20231231x10k040.jpg GRAPHIC 22432
34 GRAPHIC apge-20231231x10k041.jpg GRAPHIC 37493
35 GRAPHIC apge-20231231x10k042.jpg GRAPHIC 24416
36 GRAPHIC apge-20231231x10k043.jpg GRAPHIC 15667
37 GRAPHIC apge-20231231x10k045.jpg GRAPHIC 16429
38 GRAPHIC apge-20231231x10k047.jpg GRAPHIC 62331
39 GRAPHIC apge-20231231x10k048.jpg GRAPHIC 36761
40 GRAPHIC apge-20231231xex97d1001.jpg GRAPHIC 19687
  Complete submission text file 0001558370-24-002406.txt   12890620

Data Files

Seq Description Document Type Size
41 EX-101.SCH apge-20231231.xsd EX-101.SCH 66131
42 EX-101.CAL apge-20231231_cal.xml EX-101.CAL 53341
43 EX-101.DEF apge-20231231_def.xml EX-101.DEF 278476
44 EX-101.LAB apge-20231231_lab.xml EX-101.LAB 573867
45 EX-101.PRE apge-20231231_pre.xml EX-101.PRE 489375
130 EXTRACTED XBRL INSTANCE DOCUMENT apge-20231231x10k_htm.xml XML 1283957
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41740 | Film No.: 24718194
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)